Manipulation of Olfactory Tight Junctions Using Papaverine to Enhance Intranasal Delivery of Gemcitabine to the Brain

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2013 Oct 15

PMID 24116937

Citations 10

Authors

Mansi Krishan

Gary A Gudelsky

Pankaj B Desai

Mary Beth Genter

Affiliations

Soon will be listed here.

Abstract

Context: Delivery of drugs from the nasal cavity to the brain is becoming more widely accepted, due to the non-invasive nature of this route and the ability to circumvent the blood brain barrier (BBB).

Objective: Because of similarities in the proteins comprising the olfactory epithelial tight junction (TJ) proteins and those of the BBB, we sought to determine whether papaverine (PV), which is known to reversibly enhance BBB permeability, could increase the delivery of intranasally administered gemcitabine to the central nervous system in rats. Experimental methods: Included intranasal administration of gemcitabine, fluorescein isothiocyanate-dextran beads and PV, histopathology, immunostaining, RT-PCR, western blot analysis, immunofluorescence localization, spectrofluorometric analysis, in vivo brain microdialysis, HPLC analysis and in vitro gemcitabine recovery.

Results And Discussion: PV transiently decreased the levels and altered immunolocalization of the TJ protein phosphorylated-occludin in the olfactory epithelium, while causing an approximately four-fold increase in gemcitabine concentration reaching the brain. The enhanced delivery was not accompanied by nasal epithelial damage or toxicity to distant organs.

Conclusions: The ability to transiently and safely increase drug delivery from the nose to the brain represents a non-invasive way to improve treatment of patients with brain disorders.

Citing Articles

Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders.

Shah P, Lalan M, Barve K Front Pharmacol. 2022; 13:974666.

PMID: 36110526 PMC: 9469903. DOI: 10.3389/fphar.2022.974666.

Olfactory Drug Aerosol Delivery with Acoustic Radiation.

Abdollahzadeh Jamalabadi M, Xi J Biomedicines. 2022; 10(6).

PMID: 35740370 PMC: 9219900. DOI: 10.3390/biomedicines10061347.

Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System.

Crowe T, Hsu W Pharmaceutics. 2022; 14(3).

PMID: 35336004 PMC: 8950509. DOI: 10.3390/pharmaceutics14030629.

Focused Ultrasound-Mediated Intranasal Brain Drug Delivery Technique (FUSIN).

Ye D, Chen H Methods Mol Biol. 2022; 2394:501-513.

PMID: 35094343 DOI: 10.1007/978-1-0716-1811-0_26.

Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery.

Zolkowska D, Wu C, Rogawski M Neurotherapeutics. 2021; 18(1):544-555.

PMID: 33405197 PMC: 8116426. DOI: 10.1007/s13311-020-00985-5.

References

Mooradian A, Morley J, Kaiser F, Davis S, Viosca S, Korenman S . Biweekly intracavernous administration of papaverine for erectile dysfunction. West J Med. 1989; 151(5):515-7. PMC: 1026783. View

de Lange S, Van Groeningen C, Kroep J, van Bochove A, Snijders J, Peters G . Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer. Ann Oncol. 2004; 15(3):484-8. DOI: 10.1093/annonc/mdh109. View

Thorne R, Pronk G, Padmanabhan V, Frey 2nd W . Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004; 127(2):481-96. DOI: 10.1016/j.neuroscience.2004.05.029. View

Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K . Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992; 77(6):842-7. DOI: 10.3171/jns.1992.77.6.0842. View

Platz J, Barath K, Keller E, Valavanis A . Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note. Neuroradiology. 2008; 50(12):1035-9. DOI: 10.1007/s00234-008-0455-x. View

Apparaju S, Gudelsky G, Desai P . Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis. Cancer Chemother Pharmacol. 2007; 61(2):223-9. DOI: 10.1007/s00280-007-0464-1. View

Santoro A, Bredenfeld H, Devizzi L, Tesch H, Bonfante V, Viviani S . Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study. J Clin Oncol. 2000; 18(13):2615-9. DOI: 10.1200/JCO.2000.18.13.2615. View

Hawkins B, Egleton R . Fluorescence imaging of blood-brain barrier disruption. J Neurosci Methods. 2005; 151(2):262-7. DOI: 10.1016/j.jneumeth.2005.08.006. View

Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S . Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien). 1997; 139(8):706-11. DOI: 10.1007/BF01420042. View

10.

da Fonseca C, Simao M, Lins I, Caetano R, Futuro D, Quirico-Santos T . Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma. J Cancer Res Clin Oncol. 2010; 137(2):287-93. DOI: 10.1007/s00432-010-0873-0. View

11.

Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

12.

Wolburg H, Lippoldt A . Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2003; 38(6):323-37. DOI: 10.1016/s1537-1891(02)00200-8. View

13.

Farrell J, Elsaleh H, Garcia M, Lai R, Ammar A, Regine W . Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer. Gastroenterology. 2008; 136(1):187-95. DOI: 10.1053/j.gastro.2008.09.067. View

14.

Argaw A, Gurfein B, Zhang Y, Zameer A, John G . VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009; 106(6):1977-82. PMC: 2644149. DOI: 10.1073/pnas.0808698106. View

15.

Fujishige K, Kotera J, Omori K . Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur J Biochem. 1999; 266(3):1118-27. DOI: 10.1046/j.1432-1327.1999.00963.x. View

16.

Levin V, Edwards M, Byrd A . Quantitative observations of the acute effects of X-irradiation on brain capillary permeability: Part I. Int J Radiat Oncol Biol Phys. 1979; 5(9):1627-31. DOI: 10.1016/0360-3016(79)90786-7. View

17.

McMullan J, Sasson C, Pancioli A, Silbergleit R . Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010; 17(6):575-82. PMC: 4149412. DOI: 10.1111/j.1553-2712.2010.00751.x. View

18.

Kudo H, Doi Y, Fujimoto S . Expressions of the multidrug resistance-related proteins in the rat olfactory epithelium: a possible role in the phase III xenobiotic metabolizing function. Neurosci Lett. 2009; 468(2):98-101. DOI: 10.1016/j.neulet.2009.10.073. View

19.

Ritschel W, Hammer G . Pharmacokinetics of papaverine in man. Int J Clin Pharmacol Biopharm. 1977; 15(5):227-8. View

20.

Wolburg H, Wolburg-Buchholz K, Sam H, Horvat S, Deli M, Mack A . Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat. Histochem Cell Biol. 2008; 130(1):127-40. DOI: 10.1007/s00418-008-0410-2. View